ArticleFrontiers in bioengineering and biotechnology2025
Innovative myopic screening platform based on smartphones.
Article in Frontiers in bioengineering and biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: To validate a novel smartphone-based approach for subjective refraction, specifically for myopia screening, offering a cost-effective and accessible tool for at-home vision assessment. Methods: A total of 230 healthy volunteers, encompassing 460 eyes, aged between 7 and 40 years (mean ± SD: 21.04 ± 7.76), and exhibiting refractive error (RE) ranging from -6.25 to +0.50 diopter (D), were deemed eligible subjects in this research. Subjective refraction assessments were conducted on all subjects, involving both the conventional phoropter examination by experienced optometrists which served as the clinical gold-standard, and the smartphone-based methodology. During smartphone measurement, the screen was gradually moved toward the eye until achieving clear differentiation of the 'E' optotypes and the astigmatic dial. The eye-to-smartphone screen distances (ESD) were calculated based on the image of iris diameter (ID) acquired by the front-facing camera of the smartphone. Applying the definitions of the far point and the rule of thirty, this allowed for the computation of sphere (S), cylinder (C), and astigmatism axis ( Results: The smartphone-based screening technique showed that it closely matched the gold-standard subjective refraction used in clinical practice. The LOAs for S, C, and spherical equivalent refraction (SER) were 0.11 ± 0.89 D, -0.03 ± 0.82 D, and 0.10 ± 0.89 D, respectively. The average deviation in measuring the Discussion: The innovative vision screening through smartphones can expand access to measuring RE, especially in home. The study confirms the validity of an innovative vision-screening approach for myopia. Its effectiveness and accessibility make it a valuable tool for opportunistic or large-scale myopia screening programs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.